SIGX-2649

N/A

Report date: 2026/01/16 17:44:51
NMEFirst In Class

Base Information

Drug NameSIGX-2649
Drug Alias NameSIGX2649SIGX-2649
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional enhancer factor inhibitors
TargetsTranscriptional enhancer factor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSeeker Shengke (Shenzhen) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSeeker Shengke (Shenzhen) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A